Logo do repositório
 
Publicação

Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions : a systematic review of clinical research

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorPereira, Inês Novo
dc.contributor.authorDurão, Sara
dc.contributor.authorHassan, Haidar
dc.contributor.authorBraga, Ana Cristina
dc.contributor.authorAlmeida, André Mariz de
dc.contributor.authorManso, Ana Cristina
dc.contributor.authorFaria- Almeida, Ricardo
dc.contributor.authorCanales, Giancarlo De la Torre
dc.date.accessioned2026-04-28T15:21:02Z
dc.date.available2026-04-28T15:21:02Z
dc.date.issued2025-12
dc.description.abstractBotulinum toxin type A (BoNT) has emerged as a potential alternative to conventional therapies to many debilitating chronic diseases characterised by inflammatory states. However, the biological rationale remains ambiguous. Our review aimed to systematically assessed which biochemical biomarkers have been reported in clinical research to evaluate BoNT analgesic and mood-lifting effects in head and neck chronic conditions related to inflammation. We searched databases and registries between inception and September 29, 2023. Of the nine included studies, there were concerns about risk of bias for six studies. The leading biomarker with five studies was the calcitonin gene-related peptide (CGRP), followed by serotonin with two studies. Oxidative stress biomarkers were only reported in one study. Several important players in inflammatory processes and different immune cell classes have been evaluated in four studies. There was only one trial measuring changes in beta Tubulin and SNAP-25, and another study evaluating cutaneous neuropeptide substance-P. After BoNT, a significant effect was reported in six studies, including decrease in plasma levels of CGRP in chronic migraine and trigeminal neuralgia; serotonin decrease when collected from human tears in refractory intractable dry eye disease and increase in peripheral blood platelets in painful cervical dystonia associated to depression and anxiety; decrease in plasma concentration of markers of oxidative damage to proteins and increase in biomarkers for antioxidant power; decrease in expression of gene sets involved in inflammatory pathways and immune cells classes in the periosteum and metalloproteinase-9 molecule in the tears. BoNT seems to affect some biomarkers present in chronic inflammatory conditions. However, the certainty evidence found was very low to moderate. This study is registered on PROSPERO (CRD42023432131).eng
dc.identifier.citationNovo Pereira, I., Durão, S., Hassan, H. et al. Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research. J Neural Transm 132, 1851–1874 (2025). https://doi.org/10.1007/s00702-024-02869-w
dc.identifier.doi10.1007/s00702-024-02869-w
dc.identifier.issn1435-1463
dc.identifier.urihttp://hdl.handle.net/10400.26/62929
dc.language.isoeng
dc.peerreviewedyes
dc.publisherSpringer Nature
dc.relation.hasversionhttps://doi.org/10.1007/s00702-024-02869-w
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBotulinum Toxin
dc.subjectbiomarkers
dc.subjectinflammation
dc.subjectchronic conditions
dc.subjecthead and neck
dc.subjectclinical research
dc.titleBotulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions : a systematic review of clinical researcheng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.endPage1874
oaire.citation.startPage1851
oaire.citation.titleJournal of Neural Transmission
oaire.citation.volume132
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_GDeLaTorreCanales_2025_02.pdf
Tamanho:
2.9 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: